Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas

British Journal of Cancer

Volumn 78, Issue 9, 1998, Pages 1208-1213

  Steffens, M G ^a   Oosterwijk, E ^a   Zegwaart Hagemeier, N E ^a   Van't Hof, M A ^a   Debruyne, F M ^a   Corstens, F H ^a   Boerman, O C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heterogeneous antibody uptake; Immunohistochemistry; Monoclonal antibody cG250; Renal cell carcinoma

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL; CASE REPORT; CELL HETEROGENEITY; CELL VIABILITY; CORRELATION FUNCTION; DENSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MULTIPLE REGRESSION; PRIORITY JOURNAL;

EID: 0031725943     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.656     Document Type: Article

References (19)

1. Blumenthal RD, Sharkey RM, Kashi R, Natale AM and Goldenberg DM (1992) Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas. Int J Cancer 51: 935-941
2. Boucher Y, Leunig M and Jain RK (1996) Tumor angiogenesis and interstitial hypertension. Cancer Res 56: 4264-4266
3. Buist MR, Kenemans P, Molthoff CF, Roos JC, den Hollander W, Brinkhuis M and Baak JP (1995) Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristics. Int J Cancer 64: 92-98
4. Delisser HM, Newman PJ and Albelda SM (1993) Platelet endothelial cell adhesion molecule (CD31). Curr Top Microbiol Immunol 184: 37-45
5. Fujimori K, Covell DG, Reicher JE and Weinstein JN (1990) A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J Nucl Med 31: 1191-1198
6. Greiner JW, Hand PH, Colcher D, Weeks M, Thor A, Noguchi P, Pestka S and Schlom J (1987) Modulation of human tumor antigen expression. J Lab Clin Med 109: 244-261
7. Jain RK (1990) Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 50: 814s-819s
8. Juweid M, Sharkey RM, Markowitz A, Behr T, Swayne LC, Dunn R, Hansen HJ, Shevitz J, Leung SO, Rubin AD, Herskovic T, Hanley D and Goldenberg DM (1995) Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. Cancer Res 55: 5899s-5907s
9. Kaminski MS, Zasadny KR, Francis IR, Fenner MC, Ross CW, Milik AW, Estes J, Tuck M, Regan D, Fisher S, Glenn SD and Wahl RL (1996) Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol 14: 1974-1981
10. Murray JL, Macey DJ, Gram EJ, Rosenblum MG, Kasi LP, Zhang HZ, Katz RL, Riger PT, Lebherz D, Bhadkamkar V, Greiner JW, Schlomm J and Podoloff DA (1995) Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment. Cancer Res 55: 5925s-5928s
11. Oosterwijk E, Ruiter DJ, Hoedemaker PJ, Pauwels EK, Jonas U, Zwartendijk J and Warnaar SO (1986) Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney. Int J Cancer 38: 489-194
12. Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, Carswell EA, Larson SM, Wamaar SO, Fleuren GJ, Oettgen HF and Old U (1993) Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol 11: 738-750
13. Press OW, Eary JF, Appelbaum FR, Martin PJ, Nelp WB, Glenn S, Fisher DR, Porter B, Matthews DC, Gooley T and Bernstein ID (1995) A phase II trial of 1311-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet 346: 336-340
14. Ramaekers F, van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, Schaart G and Vooijs P (1990) Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 136: 641-655
15. Schlingemann RO, Dingjan GM, Emeis JJ, Block J, Wamaar SO and Ruiter DJ (1985) Monoclonal antibody PAL-E specific for endothelium. Lab Invest 52: 71-76
16. Shockley TR, Lin K, Sung C, Nagy JA, Tompkins RG, Dedrick RL, Dvorak HF and Yarmush ML (1992) A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Cancer Res 52: 357-366
17. Steffens MG, Boerman OC, Oosterwijk-Wakka JC, Witjes JA, Koenders EB, Oyen WJG, Buijs WCAM, Debruyne FMJ, Corstens FHM and Oosterwijk E (1997) Targeting of renal cell carcinoma with iodine-131 labeled chimeric monoclonal antibody G250. J Clin Oncol 15: 1529-1537
18. Wilder RB, Langmuir VK, Mendonca HL, Goris ML and Knox SJ (1993) Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts. Cancer Res 53: 3022-3027
19. Wilder RB, Denardo GL and Denardo SJ (1996) Radioimmunotherapy: recent results and future directions. J Clin Oncol 14: 1383-1400